A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.

Rubin S, Boulestreau R, Gosse P, Combe C.

DOI: 10.1093/ndt/gfaa313
Published: 2021-04-01
Container: Nephrol Dial Transplant
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ndt/gfaa313,
  title = {A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.},
  author = {Rubin S and  Boulestreau R and  Gosse P and  Combe C.},
  year = {2021},
  journal = {Nephrol Dial Transplant},
  doi = {10.1093/ndt/gfaa313},
  url = {https://doi.org/10.1093/ndt/gfaa313}
}

RIS

TY  - JOUR
TI  - A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.
AU  - Rubin S
AU  -  Boulestreau R
AU  -  Gosse P
AU  -  Combe C.
PY  - 2021
JO  - Nephrol Dial Transplant
DO  - 10.1093/ndt/gfaa313
UR  - https://doi.org/10.1093/ndt/gfaa313
ER  -

APA

S, R., R, B., P, G., & C., C. (2021). A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfaa313

Source records

europe-pmc · retrieved 2026-09-25T05:54:32.479Z
hal · retrieved 2026-09-25T05:54:32.501Z